Navigation Links
Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments
Date:12/14/2009

HELSINKI, Dec. 14 /PRNewswire-FirstCall/ -- Cancer patients in Finland have gained access to more advanced treatments with the introduction of RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR) at the only private radiotherapy clinic in the Nordic region. Clinicians at Docrates Clinic in Helsinki are using this fast and precise form of radiotherapy to treat patients with multiple brain metastases and cancers of the abdomen and prostate.

RapidArc, which enables clinicians to deliver a highly-precise image-guided intensity-modulated radiotherapy treatment in as little as one or two revolutions of the treatment machine around the patient, has been delivered using two Varian Clinac iX medical linear accelerators since the summer at Docrates Clinic.

"We have treated thirty prostate patients with RapidArc to date and it has achieved excellent dose coverage with low dose to nearby critical organs and healthy tissue," says Timo Kiljunen, medical physicist. "RapidArc is used routinely where pelvic lymph nodes are treated simultaneously with lower daily dose than the prostate and we also use it for metastatic and primary cancers in the abdominal region, such as liver and pancreatic cancers."

Chief oncologist Mauri Kouri, adds, "RapidArc has been very helpful in treating multiple brain metastases. In one case, four separate brain metastases were treated with two arcs and total irradiated high dose volume was estimated to be a third of that with conventional dynamic arc treatments." Dr. Kouri said RapidArc has enabled his team to introduce a new treatment model for head and multiple brain tumor treatments, sparing the hippocampus areas in prophylactic radiotherapy. "Sparing the hippocampus has been proven to reduce the effects on the patient's memory," said Dr. Kouri.

Faster tr
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
2. Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer
3. Data From Three Clinical Studies of bioTheranostics Breast Cancer Molecular Test Presented at CTRC-AACR San Antonio Breast Cancer Symposium
4. Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies
5. GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer
6. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
7. Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer
8. Shanghai ChemPartner Is Pleased to be Part of Agios Groundbreaking Cancer Research
9. For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain
10. New FDA Approved Breast Cancer Screening Tool
11. European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  In Detroit, where three out ... rate is two and one half times of the national ... of 10 infants that die in Detroit ... statistics that Covenant Community Care, a faith-based, charitable non-profit Community ... to change thanks to a charitable donation by Konica Minolta ...
(Date:4/17/2015)... 17, 2015 Steven Rash , the CEO ... its operating subsidiary American Seed & Oil Company, presented ... investors yesterday in New York City.  Mr. Rash,s presentation ... American Seed & Oil Company has recently announced the ... Hemp Seed Foods , the EpiVape , and ...
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... of the "The Corporate Reputation of Pharma ... Edition " report to their offering. ... Perspective, is now in its fourth edition. This ... early 2015). For each annual Corporate Reputation report, ...
Breaking Medicine Technology:Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2
... Bioequivalence , LONDON, UK and ATLANTA, US, May ... Pharma. Inc. (NASDAQ:SCRX) today,announce the successful completion of ... Sular, a calcium ,channel blocking agent for the ... that the new Sular formulation is,bioequivalent to Sciele's ...
... from placebo,controlled phase IIa study in patients ... (Zurich), Switzerland, May 15, 2007 - Cytos ... a multi-centre,and placebo-controlled phase IIa study with ... for the,treatment of allergic diseases. The study ...
Cached Medicine Technology:SkyePharma and Sciele Pharma Announce Successful Completion of New,Sular Formulation Clinical Trial Programme 2SkyePharma and Sciele Pharma Announce Successful Completion of New,Sular Formulation Clinical Trial Programme 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 2Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 3Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 4Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 5Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 6Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy 7
(Date:4/17/2015)... (PRWEB) April 17, 2015 At the ... EcoLuxe Lounge and the “Salute to the Oscars” in ... Beverly Hilton Hotel, overlooking the impressive Los Angeles skyline. ... organized by Debbie Durkin, LA’s leading producer of sustainable ... many of the world’s premier providers of eco-friendly and ...
(Date:4/17/2015)... 17, 2015 Baptist Health and The ... a partnership agreement designed to transform oncology care in ... have agreed to create a joint cancer program to ... translational research. Baptist MD Anderson Cancer Center is anticipated ... single destination for highly coordinated, multidisciplinary cancer care for ...
(Date:4/17/2015)... The American College of Traditional Chinese Medicine (ACTCM) is ... April 29. The event will be held from 11 a.m. to ... St. in San Francisco, CA. , The agenda for the day ... DeHaro campus (room F), 11:10 a.m. – Introduction and welcome ... lunch with current students, faculty and staff, 1 p.m. – Observe ...
(Date:4/17/2015)... Compare-autoinsurance.org has released a new blog post ... insurance quotes . , The online environment can ... cars. Drivers should always compare multiple car insurance policies ... is a competitive one, which means that customers can ... It is now possible to compare online car insurance ...
(Date:4/17/2015)... released a new blog post explaining the dangers of sleeping ... rates . , Falling asleep at the wheel can ... impact on auto insurance prices. The premiums will go up ... newly released blog post talks more about drowsiness at the ... is now possible to find low cost car insurance plans ...
Breaking Medicine News(10 mins):Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:American College of Traditional Chinese Medicine Hosts Open House 2Health News:The Best Auto Insurance Quotes Are Available Online! 2Health News:Accidents Caused By Sleeping at The Wheel Can Increase Auto Insurance Costs 2
... help avoid treatment toxicity, research shows , WEDNESDAY, Sept. ... researchers may have found a better way for them ... , A regimen using antibodies instead of high-dose ... to Dr. Persis J. Amrolia, a doctor in the ...
... , ROCHESTER, N.Y., Sept. 2 "Everyone ... flu virus. Let me tell you about my personal encounter ... article on Dr. Hanan Polansky,s book, where he describes his ... After I read the article, I started taking Gene-Eden, a ...
... Agreement to Sell MDS Analytical Technologies to Danaher, ... Shareholders;, Announces Intent to Sell MDS Pharma Services, ... MDS; NYSE: MDZ ), a leading provider of products ... it has entered into an agreement to sell its MDS Analytical ...
... , , ... (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, ... and distribute an authorized generic version of Rocaltrol(R) (calcitriol) in both ... for calcitriol softgel capsules and oral liquid were $70 million (IMS ...
... , THE WOODLANDS, Texas, Sept. 2 ... LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough ... Sands, M.D., Ph.D. , Lexicon,s president and chief executive officer, ... Four Seasons Hotel in Boston, Massachusetts on Wednesday, September 9, 2009 ...
... ... bill compliance auditing, today announced their partnership with Pat Palmer, President and Founder of ... of whom are pioneers in the field of medical bill advocacy. , ... Boca Raton, FL (PRWEB) September ...
Cached Medicine News:Health News:New Technique Offers Hope for Kids With Immune Deficiency 2Health News:How to Protect Against the Swine Flu Virus: 'My Personal Experience with Gene-Eden(TM), a Broad Range Antiviral Supplement' 2Health News:MDS Announces Strategic Repositioning 2Health News:MDS Announces Strategic Repositioning 3Health News:MDS Announces Strategic Repositioning 4Health News:MDS Announces Strategic Repositioning 5Health News:MDS Announces Strategic Repositioning 6Health News:MDS Announces Strategic Repositioning 7Health News:MDS Announces Strategic Repositioning 8Health News:MDS Announces Strategic Repositioning 9Health News:Ranbaxy Launches Authorized Generic Version of Rocaltrol(R) 2Health News:Ranbaxy Launches Authorized Generic Version of Rocaltrol(R) 3Health News:Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2Health News:TrueFACS Announces the Addition of Nora Johnson and Pat Palmer of Medical Billing Advocates of America 2
Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle....
Brightness acuity tester....
Stainless steel flexible ruler. graduated in 1/32 inches (.8 mm) fractions, as well as mm graduations....
Measures up to 152 mm in 1 mm increments and 6 inches in 1/32 inch increments. Deeply etched graduations and dull finish....
Medicine Products: